Results 181 to 190 of about 72,800 (252)

Epstein-Barr virus-associated lymphoma: current understanding and treatment strategies. [PDF]

Blood Res
Ju HY.
europepmc   +1 more source

Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4529-4545, June 2026.
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley   +1 more source

Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations. [PDF]

Viruses
Burner DN, López GY, Low JT, Luftig MA.
europepmc   +1 more source

Age-Dependent Clinical Patterns of Primary Epstein-Barr Virus Infection in Children: Insights for Diagnostic Accuracy. [PDF]

Pathogens
Teker-Düztaş D, Kaman A, Tanır G.
europepmc   +1 more source

Cancer‐Associated Fibroblasts in Invasion Front Can be a Prognostic Predictor for Oral Squamous Cell Carcinoma

Pathology International, Volume 76, Issue 6, June 2026.
Tumor immune microenvironment (TME) is an important pathogenic component in cancer, and a therapeutic target. To examine the role of the TME, especially cancer‐ associated fibroblasts (CAFs) in oral squamous cell carcinoma (SCC), a retrospective cohort study of 684 patients with surgically resected tissues was performed. Immunohistochemical analysis of
Yuuki Ishii, Joaquim Carreras, Yukie Yara Kikuchi, Yusuke Kondo, Masashi Sasaki, Takayuki Aoki, Yoshihide Ota, Naoya Nakamura   +7 more
wiley   +1 more source

Case Report: Beyond conventional diagnostics: mNGS support in a complex immunocompromised patient diagnosis. [PDF]

Front Med (Lausanne)
Scutari R, Fox V, Mastropaolo M, Fini V, Mussa M, Bigliano P, Colagrossi L, Vrenna G, Perinzano A, Scabini S, Perno CF, Calcagno A.   +11 more
europepmc   +1 more source

The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus. [PDF]

Hum Vaccin Immunother
Akingbola A, Idahor C, Adegbesan A, Fakiyesi T, Aikulola O, Tundealao S, Mariaria P.   +6 more
europepmc   +1 more source

ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus. [PDF]

Blood Sci
Hanna CS, Hamouche R, Godin SL, Rufo G, Kumar S.   +4 more
europepmc   +1 more source

Kidney transplantation after chronic active Epstein-Barr virus infection remission. [PDF]

CEN Case Rep
Tashiro Y, Hyodo Y, Kitamura S, Endo T, Nishioka S, Yokoyama N, Suzuki K, Hara T, Chiba K, Miyake H.   +9 more
europepmc   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source